{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T19:21:19Z","timestamp":1770492079285,"version":"3.49.0"},"reference-count":47,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2022,1,8]],"date-time":"2022-01-08T00:00:00Z","timestamp":1641600000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013298","name":"Sociedad Espa\u00f1ola de Reumatolog\u00eda","doi-asserted-by":"publisher","award":["Grant from \u201cFundaci\u00f3n Espa\u00f1ola de Reumatolog\u00eda\u201d 2018 for nonfunded projects."],"award-info":[{"award-number":["Grant from \u201cFundaci\u00f3n Espa\u00f1ola de Reumatolog\u00eda\u201d 2018 for nonfunded projects."]}],"id":[{"id":"10.13039\/501100013298","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>Objective: To describe postprandial lipidemia in patients with rheumatoid arthritis (RA) and to analyze its association with subclinical atherosclerosis and inflammatory activity. Methods: Observational study of 80 cases of RA and 80 sex- and age-matched controls. We excluded individuals with dyslipidemia. Postprandial hyperlipidemia (PPHL) was defined as postprandial triglycerides &gt;220 mg\/dL and\/or postprandial ApoB48 levels &gt;75th percentile (&gt;p75). Plasma lipids, cholesterol, triglycerides, ApoB48, and total ApoB were evaluated at baseline and after a meal. Other variables analyzed included subclinical atherosclerosis (defined as presence of carotid atheromatous plaque), inflammatory activity (disease activity score (DAS28-ESR)), cytokines, apolipoproteins, and physical activity. A multivariate analysis was performed to identify factors associated with PPHL in patients with RA. Results: A total of 75 patients with RA and 67 healthy controls fulfilled the inclusion criteria. PPHL was more frequent in patients with RA than controls (No. (%), 29 (38.70) vs. 15 (22.40); p = 0.036), as was subclinical atherosclerosis (No. (%), 22 (30.10) vs. 10 (14.90); p = 0.032). PPHL in patients with RA was associated with subclinical atherosclerosis (OR (95% CI) 4.69 (1.09\u201312.11); p = 0.037), TNF-\u03b1 (OR (95% CI) 2.00 (1.00\u20133.98); p = 0.048), high-sensitivity C-reactive protein (OR (95% CI) 1.10 (1.01\u20131.19); p = 0.027), and baseline triglycerides (OR (95% CI) 1.02 (1.00\u20131.04); p = 0.049). Conclusion: PPHL was more frequent in patients with RA than in controls. PPHL in patients with RA was associated with inflammation and subclinical atherosclerosis.<\/jats:p>","DOI":"10.3390\/biomedicines10010133","type":"journal-article","created":{"date-parts":[[2022,1,9]],"date-time":"2022-01-09T20:29:26Z","timestamp":1641760166000},"page":"133","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Postprandial Hyperlipidemia: Association with Inflammation and Subclinical Atherosclerosis in Patients with Rheumatoid Arthritis"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6173-2051","authenticated-orcid":false,"given":"Natalia","family":"Mena-V\u00e1zquez","sequence":"first","affiliation":[{"name":"Instituto de Investigaci\u00f3n Biom\u00e9dica de M\u00e1laga (IBIMA), 29010 Malaga, Spain"},{"name":"UGC de Reumatolog\u00eda, Hospital Regional Universitario de M\u00e1laga, 29009 Malaga, Spain"},{"name":"Departamento de Medicina y Dermatolog\u00eda, Universidad de M\u00e1laga, 29010 Malaga, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roc\u00edo","family":"Redondo-Rodr\u00edguez","sequence":"additional","affiliation":[{"name":"Instituto de Investigaci\u00f3n Biom\u00e9dica de M\u00e1laga (IBIMA), 29010 Malaga, Spain"},{"name":"UGC de Reumatolog\u00eda, Hospital Regional Universitario de M\u00e1laga, 29009 Malaga, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1196-0352","authenticated-orcid":false,"given":"Jos\u00e9","family":"Rioja","sequence":"additional","affiliation":[{"name":"Instituto de Investigaci\u00f3n Biom\u00e9dica de M\u00e1laga (IBIMA), 29010 Malaga, Spain"},{"name":"Departamento de Medicina y Dermatolog\u00eda, Universidad de M\u00e1laga, 29010 Malaga, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco Gabriel","family":"Jimenez-Nu\u00f1ez","sequence":"additional","affiliation":[{"name":"Instituto de Investigaci\u00f3n Biom\u00e9dica de M\u00e1laga (IBIMA), 29010 Malaga, Spain"},{"name":"UGC de Reumatolog\u00eda, Hospital Regional Universitario de M\u00e1laga, 29009 Malaga, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2284-7846","authenticated-orcid":false,"given":"Sara","family":"Manrique-Arija","sequence":"additional","affiliation":[{"name":"Instituto de Investigaci\u00f3n Biom\u00e9dica de M\u00e1laga (IBIMA), 29010 Malaga, Spain"},{"name":"UGC de Reumatolog\u00eda, Hospital Regional Universitario de M\u00e1laga, 29009 Malaga, Spain"},{"name":"Departamento de Medicina y Dermatolog\u00eda, Universidad de M\u00e1laga, 29010 Malaga, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9125-2208","authenticated-orcid":false,"given":"Jose Manuel","family":"Lisbona-Monta\u00f1ez","sequence":"additional","affiliation":[{"name":"UGC de Reumatolog\u00eda, Hospital Regional Universitario de M\u00e1laga, 29009 Malaga, Spain"},{"name":"Departamento de Medicina y Dermatolog\u00eda, Universidad de M\u00e1laga, 29010 Malaga, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Cano-Garc\u00eda","sequence":"additional","affiliation":[{"name":"Instituto de Investigaci\u00f3n Biom\u00e9dica de M\u00e1laga (IBIMA), 29010 Malaga, Spain"},{"name":"UGC de Reumatolog\u00eda, Hospital Regional Universitario de M\u00e1laga, 29009 Malaga, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8290-3542","authenticated-orcid":false,"given":"Marta","family":"Rojas-Gimenez","sequence":"additional","affiliation":[{"name":"UGC de Reumatolog\u00eda, Instituto Maim\u00f3nides de Investigaci\u00f3n Biom\u00e9dica de Cordoba (IMIBIC), Hospital Universitario Reina Sofia, 14004 Cordoba, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inmaculada","family":"Ure\u00f1a","sequence":"additional","affiliation":[{"name":"Instituto de Investigaci\u00f3n Biom\u00e9dica de M\u00e1laga (IBIMA), 29010 Malaga, Spain"},{"name":"UGC de Reumatolog\u00eda, Hospital Regional Universitario de M\u00e1laga, 29009 Malaga, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4458-9833","authenticated-orcid":false,"given":"Pedro","family":"Valdivielso","sequence":"additional","affiliation":[{"name":"Instituto de Investigaci\u00f3n Biom\u00e9dica de M\u00e1laga (IBIMA), 29010 Malaga, Spain"},{"name":"Departamento de Medicina y Dermatolog\u00eda, Universidad de M\u00e1laga, 29010 Malaga, Spain"},{"name":"UGC de Medicina Interna, Hospital Universitario Virgen de la Victoria, 29010 Malaga, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2962-9844","authenticated-orcid":false,"given":"Antonio","family":"Fern\u00e1ndez-Nebro","sequence":"additional","affiliation":[{"name":"Instituto de Investigaci\u00f3n Biom\u00e9dica de M\u00e1laga (IBIMA), 29010 Malaga, Spain"},{"name":"UGC de Reumatolog\u00eda, Hospital Regional Universitario de M\u00e1laga, 29009 Malaga, Spain"},{"name":"Departamento de Medicina y Dermatolog\u00eda, Universidad de M\u00e1laga, 29010 Malaga, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,1,8]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1136\/ard.2004.034777","article-title":"Cardiovascular admissions and mortality in an inception cohort of patients with rheumatoid arthritis with onset in the 1980s and 1990s","volume":"64","author":"Goodson","year":"2005","journal-title":"Ann. Rheum. Dis."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"e105","DOI":"10.1136\/annrheumdis-2019-215748","article-title":"Response to: \u201cInfluence of changes in cholesterol levels and disease activity on the 10-year cardiovascular risk estimated with different algorithms in rheumatoid arthritis patients\u201d by Fornaro et al","volume":"79","author":"Agca","year":"2019","journal-title":"Ann. Rheum. Dis."},{"key":"ref_3","first-page":"1403","article-title":"Inflammation, insulin resistance, and aberrant lipid metabolism as cardiovascular risk factors in rheumatoid arthritis","volume":"30","author":"Dessein","year":"2003","journal-title":"J. Rheumatol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1161\/01.CIR.0000099844.31524.05","article-title":"Explaining how \u201chigh-grade\u201d systemic inflammation accelerates vascular risk in rheumatoid arthritis","volume":"108","author":"Sattar","year":"2003","journal-title":"Circulation"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/1529-0131(200112)44:12<2737::AID-ART460>3.0.CO;2-#","article-title":"High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors","volume":"44","author":"Williams","year":"2001","journal-title":"Arthritis Rheum."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3132\/dvdr.2007.031","article-title":"Insulin resistance is an independent risk factor for atherosclerosis in rheumatoid arthritis","volume":"4","author":"Cacciapuoti","year":"2007","journal-title":"Diab. Vasc. Dis. Res."},{"key":"ref_7","first-page":"335","article-title":"Effect of a treat-to-target intervention of cardiovascular risk factors on subclinical and clinical atherosclerosis in rheumatoid arthritis: A randomised clinical trial","volume":"78","author":"Burggraaf","year":"2019","journal-title":"Ann. Rheum. Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1001\/jama.298.3.309","article-title":"Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women","volume":"298","author":"Bansal","year":"2007","journal-title":"JAMA"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1001\/jama.298.3.299","article-title":"Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women","volume":"298","author":"Nordestgaard","year":"2007","journal-title":"JAMA"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.2174\/0929867054546609","article-title":"Clinical relevance of postprandial lipaemia","volume":"12","author":"Kolovou","year":"2005","journal-title":"Curr. Med. Chem."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/MOL.0b013e328304b63c","article-title":"Association of fasting and nonfasting serum triglycerides with cardiovascular disease and the role of remnant-like lipoproteins and small dense LDL","volume":"19","author":"Stalenhoef","year":"2008","journal-title":"Curr. Opin. Lipidol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1046\/j.1464-5491.2001.00386.x","article-title":"Maximal post-prandial triglyceride increase reflects post-prandial hypertriglyceridaemia and is associated with the insulin resistance syndrome","volume":"18","author":"Karamanos","year":"2001","journal-title":"Diabet Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1046\/j.1365-2362.1999.00431.x","article-title":"Post-prandial chylomicron response may be predicted by a single measurement of plasma apolipoprotein B48 in the fasting state","volume":"29","author":"Smith","year":"1999","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"258","DOI":"10.2174\/157016111795495549","article-title":"Assessment and clinical relevance of non-fasting and postprandial triglycerides: An expert panel statement","volume":"9","author":"Kolovou","year":"2011","journal-title":"Curr. Vasc. Pharmacol."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Mena-V\u00e1zquez, N., Rojas-Gimenez, M., Nu\u00f1ez, F.G.J., Manrique-Arija, S., Rioja, J., Ruiz-Lim\u00f3n, P., Ure\u00f1a, I., Castro-Cabezas, M., Valdivielso, P., and Fern\u00e1ndez-Nebro, A. (2020). Postprandial Apolipoprotein B48 is Associated with Subclinical Atherosclerosis in Patients with Rheumatoid Arthritis. J. Clin. Med., 9.","DOI":"10.3390\/jcm9082483"},{"key":"ref_16","unstructured":"Burggraaf, B., van Breukelen-van der Stoep, D.F., van Zeben, J., van der Meulen, N., van de Geijn, G.-J.M., Liem, A., Valdivielso, P., Villodres, J.R., Ram\u00edrez-Bollero, J., and van der Zwan, E. (2021, November 04). Evidence for Increased Chylomicron Remnants in Rheumatoid Arthritis. Available online: https:\/\/www.myendnoteweb.com\/EndNoteWeb.html?func=downloadInstallers&cat=download&."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.cca.2013.02.005","article-title":"Fasting serum concentration of apolipoprotein B48 represents residual risks in patients with new-onset and chronic coronary artery disease","volume":"421","author":"Mori","year":"2013","journal-title":"Clin. Chim. Acta"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.cca.2009.12.022","article-title":"Postprandial Apolipoprotein B48 Is Associated With Asymptomatic Peripheral Arterial Disease: A Study in Patients With Type 2 Diabetes and Controls","volume":"411","author":"Valdivielso","year":"2010","journal-title":"Clin. Chim. Acta Int. J. Clin. Chem."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1136\/annrheumdis-2011-201148","article-title":"Effect of TNF inhibitors on lipid profile in rheumatoid arthritis: A systematic review with meta-analysis","volume":"71","author":"Duny","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","article-title":"2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"62","author":"Aletaha","year":"2010","journal-title":"Arthritis Rheum."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/j.1365-2362.2011.02635.x","article-title":"Exploring the Value of apoB48 as a Marker for Atherosclerosis in Clinical Practice","volume":"42","author":"Alipour","year":"2012","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"488","DOI":"10.3109\/s10165-009-0187-8","article-title":"Prediction of DAS28-ESR remission at 6 months by baseline variables in patients with rheumatoid arthritis treated with etanercept in Japanese population","volume":"19","author":"Iwamoto","year":"2009","journal-title":"Mod. Rheumatol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/RHU.0000000000000769","article-title":"Evaluation of Learned Helplessness, Perceived Self-efficacy, and Functional Capacity in Patients With Fibromyalgia and Rheumatoid Arthritis","volume":"25","author":"Moyano","year":"2018","journal-title":"J. Clin. Rheumatol."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (2001). Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA, 285, 2486\u20132497.","DOI":"10.1001\/jama.285.19.2486"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e13345","DOI":"10.1111\/eci.13345","article-title":"Evaluation of the chylomicron-TG to VLDL-TG ratio for type I hyperlipoproteinemia diagnostic","volume":"50","author":"Rioja","year":"2020","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1751-7141.2008.00021.x","article-title":"Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: Summary and discussion of the American Society of Echocardiography consensus statement","volume":"12","author":"Stein","year":"2009","journal-title":"Prev. Cardiol."},{"key":"ref_27","unstructured":"Martinez-Hervasa, S., Bauer-Izquierdo, S.I., Priego, M.A., Real, J.T., Carmena, R., and Ascaso, J.F. (2021, November 06). Grosor \u00cdntima-Media Carot\u00eddeo y Frecuencia de Placas de Ateroma en Poblaci\u00f3n Espa\u00f1ola Sin Factores de Riesgo Cardiovascular. Available online: https:\/\/www.myendnoteweb.com\/EndNoteWeb.html."},{"key":"ref_28","first-page":"968.e1\u201394","article-title":"ESH\/ESC 2007 Guidelines for the management of arterial hypertension","volume":"60","author":"Mancia","year":"2007","journal-title":"Rev. Esp. Cardiol."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"American Diabetes Association (2010). Diagnosis and classification of diabetes mellitus. Diabetes Care, 33, S62\u2013S69.","DOI":"10.2337\/dc10-S062"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1056\/NEJMoa1200303","article-title":"Primary Prevention of Cardiovascular Disease with a Mediterranean Diet","volume":"368","author":"Estruch","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1249\/01.MSS.0000078924.61453.FB","article-title":"International physical activity questionnaire: 12-country reliability and validity","volume":"35","author":"Craig","year":"2003","journal-title":"Med. Sci. Sports Exerc."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s10067-015-3130-8","article-title":"Increased carotid intima-media thickness in rheumatoid arthritis: An update meta-analysis","volume":"35","author":"Wang","year":"2016","journal-title":"Clin. Rheumatol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.semarthrit.2010.06.006","article-title":"Carotid intima media thickness in rheumatoid arthritis as compared to control subjects: A meta-analysis","volume":"40","author":"Peters","year":"2011","journal-title":"Semin. Arthritis Rheum."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"482","DOI":"10.3899\/jrheum.091364","article-title":"Accelerated atherosclerosis in rheumatoid arthritis: Rationale for mannose-binding lectins?","volume":"37","author":"Nakken","year":"2010","journal-title":"J. Rheumatol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"935","DOI":"10.3899\/jrheum.140694","article-title":"The Extent of Subclinical Atherosclerosis Is Partially Predicted by the Inflammatory Load: A Prospective Study over 5 Years in Patients with Rheumatoid Arthritis and Matched Controls","volume":"42","author":"Karp","year":"2015","journal-title":"J. Rheumatol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1016\/j.metabol.2005.05.008","article-title":"Fasting Apoprotein B-48 Level and Coronary Artery Disease in a Population Without Frank Fasting Hypertriglyceridemia","volume":"54","author":"Valero","year":"2005","journal-title":"Metab. Clin. Exp."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"4791","DOI":"10.1093\/eurheartj\/ehab551","article-title":"Triglyceride-rich lipoproteins and their remnants: Metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies-a consensus statement from the European Atherosclerosis Society","volume":"42","author":"Ginsberg","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"577","DOI":"10.4239\/wjd.v5.i5.577","article-title":"Peripheral arterial disease, type 2 diabetes and postprandial lipidaemia: Is there a link?","volume":"5","author":"Valdivielso","year":"2014","journal-title":"World J. Diabetes"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"van Breukelen\u2014van der Stoep, D.F., van Zeben, D., Klop, B., van de Geijn, G.J.M., Janssen, H.J.W., Hazes, M., Birnie, E., van der Meulen, N., De Vries, M.A., and Cabezas, M.C. (2015). Association of Cardiovascular Risk Factors with Carotid Intima Media Thickness in Patients with Rheumatoid Arthritis with Low Disease Activity Compared to Controls: A Cross-Sectional Study. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0140844"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"618","DOI":"10.5551\/jat.22558","article-title":"Reference interval for the apolipoprotein B-48 concentration in healthy Japanese individuals","volume":"21","author":"Masuda","year":"2014","journal-title":"J. Atheroscler. Thromb."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/S0026-0495(03)00106-9","article-title":"Fasting and Daylong Triglycerides in Obesity With and Without Type 2 Diabetes","volume":"52","author":"Halkes","year":"2003","journal-title":"Metab. Clin. Exp."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"e029861","DOI":"10.1136\/bmjopen-2019-029861","article-title":"C reactive protein level as a marker for dyslipidaemia, diabetes and metabolic syndrome: Results from the Korea National Health and Nutrition Examination Survey","volume":"9","author":"Jeong","year":"2019","journal-title":"BMJ Open"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Graf, J., Scherzer, R., Grunfeld, C., and Imboden, J. (2009). Levels of C-reactive protein associated with high and very high cardiovascular risk are prevalent in patients with rheumatoid arthritis. PLoS ONE, 4.","DOI":"10.1371\/journal.pone.0006242"},{"key":"ref_44","first-page":"1213","article-title":"Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis","volume":"32","author":"Jacobsson","year":"2005","journal-title":"J. Rheumatol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/j.1365-2362.2009.02179.x","article-title":"Methods to assess impaired post-prandial metabolism and the impact for early detection of cardiovascular disease risk","volume":"39","author":"Su","year":"2009","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.jacc.2013.01.079","article-title":"Friedewald-estimated versus directly measured low-density lipoprotein cholesterol and treatment implications","volume":"62","author":"Martin","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"57","DOI":"10.4103\/2229-516X.198525","article-title":"Correlation of Friedewald\u2019s calculated low-density lipoprotein cholesterol levels with direct low-density lipoprotein cholesterol levels in a tertiary care hospital","volume":"7","author":"Nanda","year":"2017","journal-title":"Int. J. Appl. Basic Med. Res."}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/10\/1\/133\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T13:38:15Z","timestamp":1760362695000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/10\/1\/133"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,8]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,1]]}},"alternative-id":["biomedicines10010133"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines10010133","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,8]]}}}